Vertex Pharmaceuticals Incorporated reported earnings of $ 4.76 per VRTX share on Nov 2, 2026, falling short of analysts' expectations by
| Report Date | Nov 2, 2026 |
|---|---|
| Forecasted EPS | $ 4.82 |
| Earnings Per Share (Surprise) | $ 4.76 (-$ 0.06) |
| Last Year's EPS | $ 4.60 |
| EPS YoY Change |
Out of the last 100 earnings reporting periods, Vertex Pharmaceuticals Incorporated beat analysts’ expectations 57 times and fell short of expectations 36 time(s). Vertex Pharmaceuticals Incorporated reported earnings per share of $ 4.76 in the last report falling to reach an estimated EPS of $ 4.82 by
| Report Date | Forecasted EPS | Reported EPS | Last Year's EPS | EPS YoY Change |
|---|---|---|---|---|
| Nov 2, 2026 | $ 4.82 | $ 4.76 | $ 4.80 | |
| Aug 3, 2026 | $ 4.74 | $ 4.73 | $ 4.52 | |
| May 4, 2026 | $ 4.24 | $ 4.47 | $ 4.06 | |
| Feb 12, 2026 | $ 5.11 | $ 5.03 | $ 3.98 | |
| Nov 3, 2025 | $ 4.57 | $ 4.80 | $ 4.38 | |
| Aug 4, 2025 | $ 4.29 | $ 4.52 | -$ 12.83 | |
| May 5, 2025 | $ 4.25 | $ 4.06 | $ 4.76 | |
| Feb 10, 2025 | $ 4.02 | $ 3.98 | $ 4.20 | |
| Nov 4, 2024 | $ 4.14 | $ 4.38 | $ 4.08 | |
| Aug 1, 2024 | -$ 11.63 | -$ 12.83 | $ 3.89 | |
| May 6, 2024 | $ 4.06 | $ 4.76 | $ 3.05 | |
| Feb 5, 2024 | $ 4.10 | $ 4.20 | $ 3.76 | |
| Nov 6, 2023 | $ 3.97 | $ 4.08 | $ 4.01 | |
| Aug 1, 2023 | $ 3.88 | $ 3.89 | $ 3.60 | |
| May 1, 2023 | $ 3.00 | $ 3.05 | $ 3.52 | |
| Feb 7, 2023 | $ 3.51 | $ 3.76 | $ 3.37 | |
| Oct 27, 2022 | $ 3.64 | $ 4.01 | $ 3.56 | |
| Aug 4, 2022 | $ 3.48 | $ 3.60 | $ 3.11 | |
| May 5, 2022 | $ 3.49 | $ 3.52 | $ 2.98 | |
| Jan 26, 2022 | $ 3.30 | $ 3.37 | $ 2.51 |
Vertex Pharmaceuticals Incorporated’s stock was trading at $ 558.88 on Nov 1, 2026 a day before the last earnings report was released.Following the release of the earnings report, VRTX’s price decreased to $ 530.76 on Nov 3, 2026, recording a
| Report Date | EPS | Price 1 Day Before | Price 1 Day After | Change |
|---|---|---|---|---|
| Nov 2, 2026 | $ 4.76 | $ 558.88 | $ 530.76 | |
| Aug 3, 2026 | $ 4.73 | $ 477.10 | $ 478.71 | |
| May 4, 2026 | $ 4.47 | $ 423.92 | $ 424.36 | |
| Feb 12, 2026 | $ 5.03 | $ 461.24 | $ 491.47 | |
| Nov 3, 2025 | $ 4.80 | $ 425.57 | $ 421.67 | |
| Aug 4, 2025 | $ 4.52 | $ 462.13 | $ 374.98 | |
| May 5, 2025 | $ 4.06 | $ 501.15 | $ 450.03 | |
| Feb 10, 2025 | $ 3.98 | $ 469.32 | $ 455.22 | |
| Nov 4, 2024 | $ 4.38 | $ 471.12 | $ 499.88 | |
| Aug 1, 2024 | -$ 12.83 | $ 495.72 | $ 494.46 | |
| May 6, 2024 | $ 4.76 | $ 401.08 | $ 410.24 | |
| Feb 5, 2024 | $ 4.20 | $ 424.68 | $ 416.13 | |
| Nov 6, 2023 | $ 4.08 | $ 376.20 | $ 378.25 | |
| Aug 1, 2023 | $ 3.89 | $ 352.34 | $ 358.40 | |
| May 1, 2023 | $ 3.05 | $ 340.73 | $ 346.03 | |
| Feb 7, 2023 | $ 3.76 | $ 304.87 | $ 293.33 | |
| Oct 27, 2022 | $ 4.01 | $ 311.18 | $ 313.89 | |
| Aug 4, 2022 | $ 3.60 | $ 275.03 | $ 288.03 | |
| May 5, 2022 | $ 3.52 | $ 273.70 | $ 253.93 | |
| Jan 26, 2022 | $ 3.37 | $ 227.11 | $ 228.22 |
Vertex Pharmaceuticals Incorporated released its most recent earnings reports in November 2026, August 2026, May 2026, February 2026 respectively. Generally, most companies have a consistent schedule for their earnings releases. However, companies do not necessarily release their earnings reports at the same time each year. The timing of earnings releases can vary depending on a company's fiscal year, industry norms, and internal reporting practices.
Vertex Pharmaceuticals Incorporated missed analysts’ expectations during the last earnings period by
